Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/114712
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ravn, P. | - |
dc.contributor.author | Foster, D. | - |
dc.contributor.author | Kreilgaard, M. | - |
dc.contributor.author | Christrup, L. | - |
dc.contributor.author | Werner, M. | - |
dc.contributor.author | Secher, E. | - |
dc.contributor.author | Skram, U. | - |
dc.contributor.author | Upton, R. | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | Basic and Clinical Pharmacology and Toxicology, 2014; 115(3):257-267 | - |
dc.identifier.issn | 1742-7835 | - |
dc.identifier.issn | 1742-7843 | - |
dc.identifier.uri | http://hdl.handle.net/2440/114712 | - |
dc.description.abstract | Using a modelling approach, this study aimed to (i) examine whether the pharmacodynamics of the analgesic and antihyperalgesic effects of morphine differ; (ii) investigate the influence of demographic, pain sensitivity and genetic (OPRM1) variables on between-subject variability of morphine pharmacokinetics and pharmacodynamics in human experimental pain models. The study was a randomized, double-blind, 5-arm, cross-over, placebo-controlled study. The psychophysical cutaneous pain tests, electrical pain tolerance (EPTo) and secondary hyperalgesia areas (2HA) were studied in 28 healthy individuals (15 males). The subjects were chosen based on a previous trial where 100 subjects rated (VAS) their pain during a heat injury (47°C, 7 min., 12.5 cm²). The 33% lowest- and highest pain-sensitive subjects were offered participation in the present study. A two-compartment linear model with allometric scaling for weight provided the best description of the plasma concentration-time profile of morphine. Changes in the EPTo and 2HA responses with time during the placebo treatment were best described by a linear model and a quadratic model, respectively. The model discrimination process showed clear evidence for adding between-occasion variability (BOV) on baseline and the placebo slope for EPTo and 2HA, respectively. The sensitivity covariate was significant on baseline EPTo values and genetics as a covariate on the placebo slope for 2HA. The analgesic and antihyperalgesic effects of morphine were pharmacologically distinct as the models had different effect site equilibration half-lives and different covariate effects. Morphine had negligible effect on 2HA, but significant effect on EPTo. | - |
dc.description.statementofresponsibility | Pernille Ravn, David J.R. Foster, Mads Kreilgaard, Lona Christrup, Mads U. Werner, Erik L. Secher, Ulrik Skram and Richard Upton | - |
dc.language.iso | en | - |
dc.publisher | Wiley | - |
dc.rights | © 2014 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society) | - |
dc.source.uri | http://dx.doi.org/10.1111/bcpt.12213 | - |
dc.subject | Morphine; healthy volunteers | - |
dc.title | Pharmacokinetic-pharmacodynamic modelling of the analgesic and antihyperalgesic effects of morphine after intravenous infusion in human volunteers | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1111/bcpt.12213 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Foster, D. [0000-0002-7345-4084] | - |
dc.identifier.orcid | Upton, R. [0000-0001-9996-4886] | - |
Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.